Newstral
Krishna Ella
- Bharat Biotech begins clinical trials of more effective TB vaccine in IndiaThe Times of India
- Amid rising viral cases, Bharat Biotech working on H3N2 vaccineThe Times of India
- SIndia to tighten pharmaceutical quality checks amid US ‘superbug’ outbreakscmp.com
- India preparing for big leap in quantum tech: Jitendra SinghThe Times of India
- First Indian intranasal Covid vaccine to be launched on Jan 26The Times of India
- Nasal vaccine at Rs 800 for pvt centres, Rs 325 for govt hospitalsThe Times of India
- Nasal vaccine to be priced at Rs 800/dose in pvt marketsThe Times of India
- Bharat Biotech’s nasal vaccine debuts on CoWin, but price still to be decidedThe Times of India
- Bharat Biotech's nasal vaccine will be used as booster doseThe Times of India
- World's 1st nasal Covid vax gets CDSCO approvalThe Times of India
- Live: India logs 17,135 new Covid cases, 47 deaths in 24hrsThe Times of India
- Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat BiotechThe Hindu
- The Covid Vaccine We Need Now May Not Be a ShotThe New York Times
- Padma Bhushan for Ellas, the couple behind desi Covid jab CovaxinThe Times of India
- Study: Covaxin third shot 90% effectiveThe Times of India
- Booster Shot Generates Antibodies Against Omicron And Delta Variants, Says Indian Vaccine MakerForbes
- 'Covaxin booster neutralises Omicron & Delta variants'The Times of India
- 'Covaxin booster protects against severe Covid'The Times of India
- Covaxin does not have WHO’s emergency use listing for use in childrenThe Hindu
- 'Covaxin showed better antibody response in 2-18 year olds than adults'The Times of India
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.